Literature DB >> 23097132

Wnt signalling in kidney diseases: dual roles in renal injury and repair.

Takahisa Kawakami1, Shuyu Ren, Jeremy S Duffield.   

Abstract

Wnt signalling is a complex, highly conserved, cell-to-cell communication pathway in multicellular organisms, regulating cell fate, function and phenotype in development, and diseases, including neoplasia. Although the critical role of the Wnt pathway in nephrogenesis is well established, recent investigations have shown its involvement in many adult kidney diseases, including ischaemic kidney injury, glomerular diseases, diabetic nephropathy, interstitial fibrosis and cystic kidney diseases. Overall, activation of the Wnt pathway is deleterious to many chronic diseases of the kidney, contributing to the maintenance of cells in an activated state. In addition, the Wnt pathway is activated during repair and regeneration in animal models of acute ischaemic injury, a scenario that is frequently encountered in human acute kidney injury. This activation recapitulates features of nephrogenesis and appears to play an indispensable role in repair and regeneration in this acute setting. As tools are being developed to regulate the Wnt pathway intracellularly and at the cell surface, the Wnt pathway has become a potential avenue for urgently required novel therapeutics for treating human kidney diseases. In this review, we describe consensus models for major Wnt signalling cascades and then discuss their roles in kidney diseases.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23097132     DOI: 10.1002/path.4121

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  100 in total

1.  Arrestin(g) podocyte injury with endothelin antagonism.

Authors:  Roderick J Tan; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 10.121

Review 2.  Evolution, kidney development, and chronic kidney disease.

Authors:  Robert L Chevalier
Journal:  Semin Cell Dev Biol       Date:  2018-06-05       Impact factor: 7.727

3.  Blocking TGF-β and β-Catenin Epithelial Crosstalk Exacerbates CKD.

Authors:  Stellor Nlandu-Khodo; Surekha Neelisetty; Melanie Phillips; Marika Manolopoulou; Gautam Bhave; Lauren May; Peter E Clark; Haichun Yang; Agnes B Fogo; Raymond C Harris; M Mark Taketo; Ethan Lee; Leslie S Gewin
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

4.  Exosomes to the Rescue.

Authors:  Jessica Rossol-Allison; Christopher J Ward
Journal:  J Am Soc Nephrol       Date:  2015-04-21       Impact factor: 10.121

5.  The lymph node as a new site for kidney organogenesis.

Authors:  Maria Giovanna Francipane; Eric Lagasse
Journal:  Stem Cells Transl Med       Date:  2015-02-02       Impact factor: 6.940

6.  Tubular β-catenin and FoxO3 interactions protect in chronic kidney disease.

Authors:  Stellor Nlandu-Khodo; Yosuke Osaki; Lauren Scarfe; Haichun Yang; Melanie Phillips-Mignemi; Jane Tonello; Kenyi Saito-Diaz; Surekha Neelisetty; Alla Ivanova; Tessa Huffstater; Robert McMahon; M Mark Taketo; Mark deCaestecker; Balakuntalam Kasinath; Raymond C Harris; Ethan Lee; Leslie S Gewin
Journal:  JCI Insight       Date:  2020-05-21

7.  Deletion of FHL2 in fibroblasts attenuates fibroblasts activation and kidney fibrosis via restraining TGF-β1-induced Wnt/β-catenin signaling.

Authors:  Ying Duan; Yumei Qiu; Xiaowen Huang; Chunsun Dai; Junwei Yang; Weichun He
Journal:  J Mol Med (Berl)       Date:  2020-01-11       Impact factor: 4.599

8.  Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution.

Authors:  Eric S White; Alberto R Mantovani
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

Review 9.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

10.  CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.

Authors:  Yifu Fang; Charles Ginsberg; Michael Seifert; Olga Agapova; Toshifumi Sugatani; Thomas C Register; Barry I Freedman; Marie-Claude Monier-Faugere; Hartmut Malluche; Keith A Hruska
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.